References
- Gangji V, Appelboom T. Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. Clin Rheumatol 1999; 18: 266-7. https://doi.org/10.1007/s100670050099
- Reid IR. Bisphosphonates: new indications and methods of administration. Curr Opin Rheumatol 2003; 15: 458-63. https://doi.org/10.1097/00002281-200307000-00014
- Bonabello A, Galmozzi MR, Bruzzese T, Zara GP. Analgesic effect of bisphosphonates in mice. Pain 2001; 91: 269-75. https://doi.org/10.1016/S0304-3959(00)00447-4
- Bonabello A, Galmozzi MR, Canaparo R, Serpe L, Zara GP. Long-term analgesic effect of clodronate in rodents. Bone 2003; 33: 567-74. https://doi.org/10.1016/S8756-3282(03)00229-1
- Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 2000; 88: 239-48. https://doi.org/10.1016/S0304-3959(00)00331-6
- Kawabata A, Kawao N, Hironaka Y, Ishiki T, Matsunami M, Sekiguchi F. Antiallodynic effect of etidronate, a bisphosphonate, in rats with adjuvant-induced arthritis: involvement of ATP-sensitive K+ channels. Neuropharmacology 2006; 51: 182-90. https://doi.org/10.1016/j.neuropharm.2006.03.015
- Sevcik MA, Luger NM, Mach DB, Sabino MA, Peters CM, Ghilardi JR, et al. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis. Pain 2004; 111: 169-80. https://doi.org/10.1016/j.pain.2004.06.015
- Walker K, Medhurst SJ, Kidd BL, Glatt M, Bowes M, Patel S, et al. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain 2002; 100: 219-29. https://doi.org/10.1016/S0304-3959(02)00040-4
- Yanow J, Pappagallo M, Pillai L. Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. Scientific World- Journal 2008; 8: 229-36. https://doi.org/10.1100/tsw.2008.33
- Hassenbusch SJ, Portenoy RK, Cousins M, Buchser E, Deer TR, Du Pen SL, et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. J Pain Symptom Manage 2004; 27: 540-63. https://doi.org/10.1016/j.jpainsymman.2004.03.001
- Hayashi N, Weinstein JN, Meller ST, Lee HM, Spratt KF, Gebhart GF. The effect of epidural injection of betamethasone or bupivacaine in a rat model of lumbar radiculopathy. Spine 1998; 23: 877-85. https://doi.org/10.1097/00007632-199804150-00008
- Kawakami M, Matsumoto T, Hashizume H, Kuribayashi K, Tamaki T. Epidural injection of cyclooxygenase-2 inhibitor attenuates pain-related behavior following application of nucleus pulposus to the nerve root in the rat. J Orthop Res 2002; 20: 376-81. https://doi.org/10.1016/S0736-0266(01)00114-0
- Bajrović F, Sketelj J. Extent of nociceptive dermatomes in adult rats is not primarily maintained by axonal competition. Exp Neurol 1998; 150: 115-21. https://doi.org/10.1006/exnr.1997.6734
- Ochi T, Ohkubo Y, Mutoh S. FR143166 attenuates spinal pain transmission through activation of the serotonergic system. Eur J Pharmacol 2002; 452: 319-24. https://doi.org/10.1016/S0014-2999(02)02334-8
- Sinnott CJ, Cogswell III LP, Johnson A, Strichartz GR. On the mechanism by which epinephrine potentiates lidocaine's peripheral nerve block. Anesthesiology 2003; 98: 181-8. https://doi.org/10.1097/00000542-200301000-00028
- Chatani K, Kawakami M, Weinstein JN, Meller ST, Gebhart GF. Characterization of thermal hyperalgesia, c-fos expression, and alterations in neuropeptides after mechanical irritation of the dorsal root ganglion. Spine 1995; 20: 277-89. https://doi.org/10.1097/00007632-199502000-00004
- Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 2001; 28: 465-73. https://doi.org/10.1016/S8756-3282(01)00412-4
- Body JJ, Diel IJ, Lichinitser MR, Kreuser ED, Dornoff W, Gorbunova VA, et al. Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases. Ann Oncol 2003; 14: 1399-405. https://doi.org/10.1093/annonc/mdg367
- Conte PF, Latreille J, Mauriac L, Calabresi F, Santos R, Campos D, et al. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group. J Clin Oncol 1996; 14: 2552-9. https://doi.org/10.1200/JCO.1996.14.9.2552
- Diener KM. Bisphosphonates for controlling pain from metastatic bone disease. Am J Health Syst Pharm 1996; 53: 1917-27.
- Kubalek I, Fain O, Paries J, Kettaneh A, Thomas M. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology (Oxford) 2001; 40: 1394-7. https://doi.org/10.1093/rheumatology/40.12.1394
- Robinson JN, Sandom J, Chapman PT. Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 2004; 5: 276-80. https://doi.org/10.1111/j.1526-4637.2004.04038.x
- Abildgaard N, Glerup H, Rungby J, Bendix-Hansen K, Kassem M, Brixen K, et al. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma. Eur J Haematol 2000; 64: 121-9. https://doi.org/10.1034/j.1600-0609.2000.90074.x
- Gallacher SJ, Ralston SH, Patel U, Boyle IT. Side-effects of pamidronate. Lancet 1989; 2: 42-3.
- Dodwell DJ, Howell A, Ford J. Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate. Br J Cancer 1990; 61: 123-5. https://doi.org/10.1038/bjc.1990.25
- Morton AR, Howell A. Bisphosphonates and bone metastases. Br J Cancer 1988; 58: 556-7. https://doi.org/10.1038/bjc.1988.257
- Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). Br Med J (Clin Res Ed) 1987; 295: 1301-5. https://doi.org/10.1136/bmj.295.6609.1301
- Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet 1985; 2: 907-10.
- Yaksh TL, Collins JG. Studies in animals should precede human use of spinally administered drugs. Anesthesiology 1989; 70: 4-6. https://doi.org/10.1097/00000542-198901000-00003
- Kim YC, Lim YJ, Lee SC. Spreading pattern of epidurally administered contrast medium in rabbits. Acta Anaesthesiol Scand 1998; 42: 1092-5. https://doi.org/10.1111/j.1399-6576.1998.tb05382.x